CVS Health Corp (CVS)
58.01
+0.91
(+1.59%)
USD |
NYSE |
Nov 22, 16:00
58.01
0.00 (0.00%)
After-Hours: 20:00
CVS Health Revenue (Quarterly): 95.43B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 95.43B |
| June 30, 2024 | 91.23B |
| March 31, 2024 | 88.44B |
| December 31, 2023 | 93.81B |
| September 30, 2023 | 89.76B |
| June 30, 2023 | 88.92B |
| March 31, 2023 | 85.28B |
| December 31, 2022 | 83.85B |
| September 30, 2022 | 81.16B |
| June 30, 2022 | 80.64B |
| March 31, 2022 | 76.83B |
| December 31, 2021 | 76.60B |
| September 30, 2021 | 73.79B |
| June 30, 2021 | 72.62B |
| March 31, 2021 | 69.10B |
| December 31, 2020 | 69.55B |
| September 30, 2020 | 67.06B |
| June 30, 2020 | 65.34B |
| March 31, 2020 | 66.76B |
| December 31, 2019 | 66.89B |
| September 30, 2019 | 64.81B |
| June 30, 2019 | 63.43B |
| March 31, 2019 | 61.65B |
| December 31, 2018 | 54.42B |
| September 30, 2018 | 47.49B |
| Date | Value |
|---|---|
| June 30, 2018 | 46.92B |
| March 31, 2018 | 45.74B |
| December 31, 2017 | 48.41B |
| September 30, 2017 | 46.18B |
| June 30, 2017 | 45.68B |
| March 31, 2017 | 44.51B |
| December 31, 2016 | 45.99B |
| September 30, 2016 | 44.62B |
| June 30, 2016 | 43.72B |
| March 31, 2016 | 43.22B |
| December 31, 2015 | 41.15B |
| September 30, 2015 | 38.64B |
| June 30, 2015 | 37.17B |
| March 31, 2015 | 36.33B |
| December 31, 2014 | 37.06B |
| September 30, 2014 | 35.02B |
| June 30, 2014 | 34.60B |
| March 31, 2014 | 32.69B |
| December 31, 2013 | 32.83B |
| September 30, 2013 | 31.93B |
| June 30, 2013 | 31.25B |
| March 31, 2013 | 30.75B |
| December 31, 2012 | 31.38B |
| September 30, 2012 | 30.23B |
| June 30, 2012 | 30.71B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
65.34B
Minimum
Jun 2020
95.43B
Maximum
Sep 2024
79.15B
Average
78.73B
Median
Revenue (Quarterly) Benchmarks
| Humana Inc | 29.40B |
| Eli Lilly and Co | 11.44B |
| Walgreens Boots Alliance Inc | 37.55B |
| SCWorx Corp | 0.7597M |
| AirSculpt Technologies Inc | 42.55M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 87.00M |
| Total Expenses (Quarterly) | 93.43B |
| EPS Diluted (Quarterly) | 0.07 |
| Enterprise Value | 129.02B |
| Gross Profit Margin (Quarterly) | 13.16% |
| Profit Margin (Quarterly) | 0.09% |
| Earnings Yield | 6.79% |
| Operating Earnings Yield | 14.52% |
| Normalized Earnings Yield | 7.874 |